Experimental Hematology and Oncology (EHO)

Experimental Hematology & Oncology is an international, peer-reviewed, open-access journal that focuses on cutting-edge research in hematology and oncology. The journal publishes original research articles, reviews, and clinical studies that advance the understanding of blood disorders and cancer biology. The scope includes studies on leukemia, lymphoma, myeloma, and other hematologic malignancies, as well as solid tumors with hematological relevance. It also covers molecular and cellular mechanisms of cancer, tumor immunology, stem cell biology, targeted therapies, and translational research. The journal emphasizes innovative experimental approaches, including genomics, proteomics, and precision medicine strategies aimed at improving diagnosis, treatment, and patient outcomes. By promoting interdisciplinary collaboration between basic scientists and clinicians, Experimental Hematology & Oncology aims to accelerate the translation of laboratory discoveries into clinical applications. It serves as a valuable resource for researchers, oncologists, hematologists, and healthcare professionals working to combat cancer and blood-related diseases.

Experimental Hematology and Oncology (EHO) is :-

• International, Peer-Reviewed, Open Access, Refereed, studies on leukemia, lymphoma, myeloma, and other hematologic malignancies, as well as solid tumors with hematological relevance, molecular and cellular mechanisms of cancer, tumor immunology, stem cell biology, targeted therapies, translational research, genomics, proteomics, and precision medicine strategies aimed at improving diagnosis, treatment, patient outcomes, Hematology, Oncology and Cancer Research, Molecular Biology, Clinical Medicine, Immunology and Stem Cell Research , Online , Continuously Journal

• UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2162-3619, Established: 2012,
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE